This spreadsheet lists 1,000+ cases of alleged police brutality amid George Floyd protests

The videos raise serious legal and moral questions about police crowd-control tactics.

Police officer shoves women during peaceful protest in Brooklyn

Police officer shoves women during peaceful protest in Brooklyn

via @Whitney_hu on Twitter
  • The publicly accessible Google Sheet lists more than 1,000 incidents of alleged police misconduct.
  • Each entry is organized by city, and most contain a link to a video.
  • From tear gas to rubber bullets, the videos highlight the extensive powers police are given in certain situations.

Activists have been compiling videos of violent clashes between protestors and police in the two weeks since George Floyd was killed by officer Derek Chauvin. Hundreds of these videos appear on a Google spreadsheet that currently lists more than 1,000 incidents of alleged police misconduct. Many of the scenes are surreal.

In Minneapolis, a video shows police marching down a mostly empty residential street and screaming "get inside!" to a handful of residents standing on a porch. When the group doesn't go inside, police shoot them with pepper bullets.

In San Diego, police said they witnessed a woman swing a sign at an officer on a motorcycle. It's unclear whether she did. But what a video does show is several cops arresting a woman at gunpoint, putting her inside an unmarked van, and telling her concerned friends: "If you follow us, you will get shot."

In Austin, 16-year-old Edwin Ayala attended a protest. He stood alone on a grassy hill, about a dozen yards away from police and other protestors. As Ayala stood still, an officer on the street raised his gun and shot a bean-bag bullet at the boy's head. Ayala collapsed instantly and was hospitalized.

The project is led by T. Greg Doucette, a criminal defense lawyer in North Carolina who produces the podcast Fsck 'Em All, which covers police conduct. In late May, he started posting videos of clashes between protestors and police to social media. Soon, people began sending him videos to post.

"I think 'avalanche' is probably an understatement," Doucette told TIME. "I've got close to 2,000 messages that I haven't even been able to open yet."

Doucette and his colleagues try to verify each video, such as by checking whether the media has covered an incident, or highlighting when videos show an incident from an additional vantage point. Most entries also contain commentary, such as: "police shoot out a dog walker's eye for sport."

One of the people helping with the project is Jason Miller, a mathematician in California. Miller told TIME:

"[As] I've grown up and matured, I've moved out of Minneapolis and I've reflected on my relationship with race. I've seen how the culture in Minneapolis was not a healthy culture. [...] I wanted this information to be freely distributed, and free for people to see."

To be sure, it's not always clear what's happening in these videos, or what provoked a clash. What's more, it's likely that cops technically aren't breaking any laws in some of these incidents. After all, most police in the U.S. are given the power to use pepper spray, tear gas, batons, and non-lethal bullets against civilians who are "unlawfully" assembled.

The Austin Police Department's handbook, for example, says that officers can use modified 12-gauge shotguns to shoot civilians with bean-bags if they need to "de-escalate a potentially deadly situation." (You can watch an officer shooting Edwin Ayala in the head and decide for yourself whether that officer faced a "potentially deadly situation.")

George Floyd protestors in New York CityCurrent And Former Mayor De Blasio And NYC Gov't Staffers Call On Mayor For Police Reform

Stephanie Keith / Getty

It's also worth mentioning that hundreds of police officers have been injured during protests and riots in recent weeks. In St. Louis, four officers were shot and one former police captain was killed. In Oakland, two Federal Protective Service officers were shot during a protest; one was critically injured, the other died. And in New York City, nearly 300 officers have been injured so far, according to the NYPD. (It's unclear how extensive those injuries are.)

Still, no police handbook calls for officers to pursue extralegal revenge on civilian crowds. And it seems safe to say that no public official would argue that police — no matter the circumstance — should be permitted to deliberately cover up their body cameras, pepper-spray protestors from behind as they're walking away, or chase down and beat reporters for documenting the protests.

"What we're taught in school is that all power comes from the people; the people elect their representatives, the representatives hire the bureaucrats, the bureaucrats hire the cops" Doucette told TIME. "They're supposed to be at the bottom of the rungs of power, and instead we've inverted that upside down— where the police are openly declaring war on their own citizens, and the politicians are simply sitting there, diddling their phones, not doing anything."

U.S. Navy controls inventions that claim to change "fabric of reality"

Inventions with revolutionary potential made by a mysterious aerospace engineer for the U.S. Navy come to light.

U.S. Navy ships

Credit: Getty Images
Surprising Science
  • U.S. Navy holds patents for enigmatic inventions by aerospace engineer Dr. Salvatore Pais.
  • Pais came up with technology that can "engineer" reality, devising an ultrafast craft, a fusion reactor, and more.
  • While mostly theoretical at this point, the inventions could transform energy, space, and military sectors.
Keep reading Show less

Why so gassy? Mysterious methane detected on Saturn’s moon

Scientists do not know what is causing the overabundance of the gas.

An impression of NASA's Cassini spacecraft flying through a water plume on the surface of Saturn's moon Enceladus.

Credit: NASA
Surprising Science
  • A new study looked to understand the source of methane on Saturn's moon Enceladus.
  • The scientists used computer models with data from the Cassini spacecraft.
  • The explanation could lie in alien organisms or non-biological processes.
Keep reading Show less

CRISPR therapy cures first genetic disorder inside the body

It marks a breakthrough in using gene editing to treat diseases.

Credit: National Cancer Institute via Unsplash
Technology & Innovation

This article was originally published by our sister site, Freethink.

For the first time, researchers appear to have effectively treated a genetic disorder by directly injecting a CRISPR therapy into patients' bloodstreams — overcoming one of the biggest hurdles to curing diseases with the gene editing technology.

The therapy appears to be astonishingly effective, editing nearly every cell in the liver to stop a disease-causing mutation.

The challenge: CRISPR gives us the ability to correct genetic mutations, and given that such mutations are responsible for more than 6,000 human diseases, the tech has the potential to dramatically improve human health.

One way to use CRISPR to treat diseases is to remove affected cells from a patient, edit out the mutation in the lab, and place the cells back in the body to replicate — that's how one team functionally cured people with the blood disorder sickle cell anemia, editing and then infusing bone marrow cells.

Bone marrow is a special case, though, and many mutations cause disease in organs that are harder to fix.

Another option is to insert the CRISPR system itself into the body so that it can make edits directly in the affected organs (that's only been attempted once, in an ongoing study in which people had a CRISPR therapy injected into their eyes to treat a rare vision disorder).

Injecting a CRISPR therapy right into the bloodstream has been a problem, though, because the therapy has to find the right cells to edit. An inherited mutation will be in the DNA of every cell of your body, but if it only causes disease in the liver, you don't want your therapy being used up in the pancreas or kidneys.

A new CRISPR therapy: Now, researchers from Intellia Therapeutics and Regeneron Pharmaceuticals have demonstrated for the first time that a CRISPR therapy delivered into the bloodstream can travel to desired tissues to make edits.

We can overcome one of the biggest challenges with applying CRISPR clinically.


"This is a major milestone for patients," Jennifer Doudna, co-developer of CRISPR, who wasn't involved in the trial, told NPR.

"While these are early data, they show us that we can overcome one of the biggest challenges with applying CRISPR clinically so far, which is being able to deliver it systemically and get it to the right place," she continued.

What they did: During a phase 1 clinical trial, Intellia researchers injected a CRISPR therapy dubbed NTLA-2001 into the bloodstreams of six people with a rare, potentially fatal genetic disorder called transthyretin amyloidosis.

The livers of people with transthyretin amyloidosis produce a destructive protein, and the CRISPR therapy was designed to target the gene that makes the protein and halt its production. After just one injection of NTLA-2001, the three patients given a higher dose saw their levels of the protein drop by 80% to 96%.

A better option: The CRISPR therapy produced only mild adverse effects and did lower the protein levels, but we don't know yet if the effect will be permanent. It'll also be a few months before we know if the therapy can alleviate the symptoms of transthyretin amyloidosis.

This is a wonderful day for the future of gene-editing as a medicine.


If everything goes as hoped, though, NTLA-2001 could one day offer a better treatment option for transthyretin amyloidosis than a currently approved medication, patisiran, which only reduces toxic protein levels by 81% and must be injected regularly.

Looking ahead: Even more exciting than NTLA-2001's potential impact on transthyretin amyloidosis, though, is the knowledge that we may be able to use CRISPR injections to treat other genetic disorders that are difficult to target directly, such as heart or brain diseases.

"This is a wonderful day for the future of gene-editing as a medicine," Fyodor Urnov, a UC Berkeley professor of genetics, who wasn't involved in the trial, told NPR. "We as a species are watching this remarkable new show called: our gene-edited future."